Stay updated on Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page.

Latest updates to the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page
- Check2 days agoChange DetectedThe footer’s site revision label changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check30 days agoChange DetectedA site-wide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The displayed site revision advances from v3.7.1 to v3.7.2, with no change to the study details.SummaryDifference0.8%

- Check44 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the platform as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page history now shows a new Revision: v3.7.0 entry, and the previous Revision: v3.6.6 entry is removed, updating the history to reflect the latest release.SummaryDifference0.1%

- Check79 days agoChange DetectedA new version entry, Revision: v3.6.6, was added to the history. The previous Revision: v3.6.5 entry was removed from the list.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page.